A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM

Bone Marrow Transplant. 2016 Oct;51(10):1397-1399. doi: 10.1038/bmt.2016.134. Epub 2016 May 23.

Authors

J Kothari¹, M Foley¹, K S Peggs², S Mackenzie¹, K Thomson¹, E Morris³, K M Ardeshna¹, A E Virchis¹, D C Linch², J Lambert¹

Affiliations

¹ Department of Haematology, University College Hospital, University College Hospitals NHS Trust, London, UK.
² UCL Cancer Institute, University College London, London, UK.
³ Department of Immunology, University College London, London, UK.

PMID: 27214072
DOI: 10.1038/bmt.2016.134

No abstract available

Publication types

Comparative Study
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carmustine / therapeutic use
Cytarabine / therapeutic use
Etoposide / therapeutic use
Female
Hematopoietic Stem Cell Transplantation / methods
Hematopoietic Stem Cell Transplantation / mortality
Humans
Lomustine / therapeutic use
Lymphoma / mortality
Lymphoma / therapy*
Male
Melphalan / therapeutic use
Middle Aged
Retrospective Studies
Salvage Therapy / methods
Survival Analysis
Transplantation Conditioning / methods*
Transplantation Conditioning / mortality
Transplantation Conditioning / standards
Transplantation, Autologous

Substances

Cytarabine
Etoposide
Lomustine
Melphalan
Carmustine

Supplementary concepts

BEAM regimen